Barclays’s Astria Therapeutics ATXS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $630K | Buy |
117,534
+44,901
| +62% | +$241K | ﹤0.01% | 2918 |
|
|
2025
Q1 | $389K | Sell |
72,633
-25,187
| -26% | -$135K | ﹤0.01% | 2981 |
|
|
2024
Q4 | $875K | Buy |
97,820
+5,169
| +6% | +$46.2K | ﹤0.01% | 2710 |
|
|
2024
Q3 | $1.02M | Buy |
92,651
+38,321
| +71% | +$422K | ﹤0.01% | 2611 |
|
|
2024
Q2 | $494K | Sell |
54,330
-80,877
| -60% | -$735K | ﹤0.01% | 2547 |
|
|
2024
Q1 | $1.9M | Buy |
135,207
+85,793
| +174% | +$1.21M | ﹤0.01% | 1969 |
|
|
2023
Q4 | $379K | Buy |
49,414
+40,996
| +487% | +$314K | ﹤0.01% | 3154 |
|
|
2023
Q3 | $62K | Sell |
8,418
-592
| -7% | -$4.36K | ﹤0.01% | 3502 |
|
|
2023
Q2 | $75K | Sell |
9,010
-23,987
| -73% | -$200K | ﹤0.01% | 3507 |
|
|
2023
Q1 | $439K | Buy |
+32,997
| New | +$439K | ﹤0.01% | 2726 |
|
|
2021
Q3 | – | Sell |
-885
| Closed | -$11K | – | 3949 |
|
|
2021
Q2 | $11K | Sell |
885
-5,269
| -86% | -$65.5K | ﹤0.01% | 3824 |
|
|
2021
Q1 | $107K | Buy |
6,154
+1,732
| +39% | +$30.1K | ﹤0.01% | 3348 |
|
|
2020
Q4 | $57K | Buy |
4,422
+2,962
| +203% | +$38.2K | ﹤0.01% | 3138 |
|
|
2020
Q3 | $54K | Sell |
1,460
-192
| -12% | -$7.1K | ﹤0.01% | 3252 |
|
|
2020
Q2 | $64K | Buy |
+1,652
| New | +$64K | ﹤0.01% | 3306 |
|
|
2018
Q2 | – | Sell |
-30
| Closed | -$3K | – | 4183 |
|
|
2018
Q1 | $3K | Buy |
+30
| New | +$3K | ﹤0.01% | 4053 |
|
|
2016
Q3 | – | Sell |
-1
| Closed | – | – | 3922 |
|
|
2016
Q2 | $0 | Buy |
+1
| New | – | ﹤0.01% | 3595 |
|